RhumbLine Advisers’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $461K | Sell |
348,942
-12,021
| -3% | -$21.5K | ﹤0.01% | 2663 |
|
|
2025
Q4 | $675K | Sell |
360,963
-54,716
| -13% | -$105K | ﹤0.01% | 2469 |
|
|
2025
Q3 | $532K | Buy |
415,679
+8,532
| +2% | +$11.6K | ﹤0.01% | 2656 |
|
|
2025
Q2 | $505K | Sell |
407,147
-31,628
| -7% | -$36.5K | ﹤0.01% | 2678 |
|
|
2025
Q1 | $518K | Buy |
438,775
+20,153
| +5% | +$30.9K | ﹤0.01% | 2561 |
|
|
2024
Q4 | $766K | Buy |
418,622
+5,722
| +1% | +$11.2K | ﹤0.01% | 2390 |
|
|
2024
Q3 | $702K | Sell |
412,900
-23,968
| -5% | -$39.4K | ﹤0.01% | 2478 |
|
|
2024
Q2 | $598K | Buy |
436,868
+51,727
| +13% | +$104K | ﹤0.01% | 2547 |
|
|
2024
Q1 | $1.44M | Buy |
385,141
+1,823
| +0.5% | +$10.7K | ﹤0.01% | 2072 |
|
|
2023
Q4 | $3.76M | Buy |
383,318
+334
| +0.1% | +$2.73K | ﹤0.01% | 1584 |
|
|
2023
Q3 | $3.2M | Buy |
382,984
+1,393
| +0.4% | +$15.9K | ﹤0.01% | 1601 |
|
|
2023
Q2 | $5.08M | Sell |
381,591
-21,914
| -5% | -$266K | 0.01% | 1361 |
|
|
2023
Q1 | $4.67M | Buy |
403,505
+44,460
| +12% | +$442K | 0.01% | 1363 |
|
|
2022
Q4 | $2.94M | Buy |
359,045
+6,237
| +2% | +$53.7K | ﹤0.01% | 1587 |
|
|
2022
Q3 | $2.05M | Buy |
352,808
+23,329
| +7% | +$134K | ﹤0.01% | 1746 |
|
|
2022
Q2 | $1.46M | Buy |
329,479
+92,677
| +39% | +$563K | ﹤0.01% | 1940 |
|
|
2022
Q1 | $2.15M | Sell |
236,802
-8,272
| -3% | -$95.2K | ﹤0.01% | 1779 |
|
|
2021
Q4 | $5.01M | Sell |
245,074
-3,129
| -1% | -$75.5K | 0.01% | 1355 |
|
|
2021
Q3 | $6.34M | Sell |
248,203
-1,568
| -0.6% | -$46.5K | 0.01% | 1211 |
|
|
2021
Q2 | $8.73M | Buy |
249,771
+34,330
| +16% | +$998K | 0.01% | 1094 |
|
|
2021
Q1 | $7.18M | Sell |
215,441
-8,546
| -4% | -$299K | 0.01% | 1202 |
|
|
2020
Q4 | $5.81M | Buy |
223,987
+27,588
| +14% | +$469K | 0.01% | 1270 |
|
|
2020
Q3 | $1.94M | Sell |
196,399
-15,083
| -7% | -$86.8K | ﹤0.01% | 1697 |
|
|
2020
Q2 | $730K | Buy |
211,482
+17,121
| +9% | +$58.3K | ﹤0.01% | 2178 |
|
|
2020
Q1 | $595K | Sell |
194,361
-7,119
| -4% | -$29.2K | ﹤0.01% | 2103 |
|
|
2019
Q4 | $1.04M | Buy |
201,480
+3,203
| +2% | +$16.3K | ﹤0.01% | 2065 |
|
|
2019
Q3 | $1.02M | Buy |
198,277
+2,330
| +1% | +$13K | ﹤0.01% | 2029 |
|
|
2019
Q2 | $1.19M | Buy |
195,947
+15,555
| +9% | +$109K | ﹤0.01% | 1988 |
|
|
2019
Q1 | $1.3M | Buy |
180,392
+5,364
| +3% | +$38.8K | ﹤0.01% | 1909 |
|
|
2018
Q4 | $1.29M | Buy |
175,028
+64,940
| +59% | +$411K | ﹤0.01% | 1887 |
|
|
2018
Q3 | $596K | Sell |
110,088
-6,872
| -6% | -$29.5K | ﹤0.01% | 2210 |
|
|
2018
Q2 | $415K | Buy |
116,960
+17,005
| +17% | +$47.2K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $205K | Sell |
99,955
-1,155
| -1% | -$3K | ﹤0.01% | 2592 |
|
|
2017
Q4 | $267K | Sell |
101,110
-7,474
| -7% | -$26.2K | ﹤0.01% | 2511 |
|
|
2017
Q3 | $570K | Buy |
108,584
+3,970
| +4% | +$17.1K | ﹤0.01% | 2250 |
|
|
2017
Q2 | $372K | Buy |
104,614
+2,650
| +3% | +$10.7K | ﹤0.01% | 2451 |
|
|
2017
Q1 | $527K | Buy |
101,964
+2,703
| +3% | +$13.2K | ﹤0.01% | 2221 |
|
|
2016
Q4 | $377K | Buy |
99,261
+6,607
| +7% | +$48K | ﹤0.01% | 2369 |
|
|
2016
Q3 | $830K | Buy |
92,654
+3,819
| +4% | +$31.9K | ﹤0.01% | 1922 |
|
|
2016
Q2 | $625K | Buy |
88,835
+11,802
| +15% | +$108K | ﹤0.01% | 2059 |
|
|
2016
Q1 | $655K | Buy |
77,033
+4,255
| +6% | +$41.8K | ﹤0.01% | 2041 |
|
|
2015
Q4 | $956K | Buy |
72,778
+7,130
| +11% | +$64K | ﹤0.01% | 1832 |
|
|
2015
Q3 | $240K | Sell |
65,648
-12,358
| -16% | -$60.4K | ﹤0.01% | 2683 |
|
|
2015
Q2 | $449K | Buy |
78,006
+980
| +1% | +$5.67K | ﹤0.01% | 2405 |
|
|
2015
Q1 | $450K | Buy |
77,026
+10,900
| +16% | +$75.2K | ﹤0.01% | 2354 |
|
|
2014
Q4 | $518K | Buy |
66,126
+11,605
| +21% | +$74.3K | ﹤0.01% | 2254 |
|
|
2014
Q3 | $268K | Sell |
54,521
-1,300
| -2% | -$6.8K | ﹤0.01% | 2590 |
|
|
2014
Q2 | $345K | Sell |
55,821
-12,673
| -19% | -$63.4K | ﹤0.01% | 2505 |
|
|
2014
Q1 | $366K | Sell |
68,494
-620
| -0.9% | -$3.92K | ﹤0.01% | 2410 |
|
|
2013
Q4 | $361K | Sell |
69,114
-2,400
| -3% | -$11K | ﹤0.01% | 2460 |
|
|
2013
Q3 | $395K | Sell |
71,514
-411
| -0.6% | -$1.43K | ﹤0.01% | 2361 |
|
|
2013
Q2 | $181K | Buy |
+71,925
| New | +$179K | ﹤0.01% | 3032 |
|
Other funds holding PACB
AIM
VCM
NAMA
